Process Development - Labor Dr. Merk in Ochsenhausen, Germany
process development, services for vaccines, services for viral therapeutics, oncolytic for viral therapeutics, collaborations, industrial partners, gmp manufacturins, clinical studies, GMP certified facilities, GLP certified facilities, constant innovation, process technology
480
page-template,page-template-full_width,page-template-full_width-php,page,page-id-480,page-child,parent-pageid-412,cookies-not-set,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-13.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Process Development

Process Development

Labor Dr. Merk & Kollegen offers numerous process development services for vaccines and viral therapeutics. Specializing early in the innovative and strongly upcoming field of viral gene therapeutics and oncolytic viral therapeutics, proved to be an excellent strategy, as many fruitful collaborations between Labor Dr. Merk & Kollegen and industrial partners emerged. The multi-level expertise that is needed for developing up-stream as well as down-stream processes for new and innovative therapeutics are merged at Labor Dr. Merk & Kollegen in a unique manner. The combination of the process development expertise and the GMP manufacturing capabilities at Labor Dr. Merk & Kollegen provides an ideal environment for successful end-to-end customer projects, culminating in material supply for phase I/II clinical studies.

 

The GMP and GLP certified facilities at Labor Dr. Merk & Kollegen are an excellent origin of a successfully developed and manufactured product.

 

Constant innovation in development and process technology is stimulated by close collaboration with academic institutions.
Labor Dr. Merk & Kollegen offers numerous process development services for vaccines and viral therapeutics. Specializing early in the innovative and strongly upcoming field of viral gene therapeutics and oncolytic viral therapeutics, proved to be an excellent strategy, as many fruitful collaborations between Labor Dr. Merk & Kollegen and industrial partners emerged. The multi-level expertise that is needed for developing up-stream as well as down-stream processes for new and innovative therapeutics are merged at Labor Dr. Merk & Kollegen in a unique manner. The combination of the process development expertise and the GMP manufacturing capabilities at Labor Dr. Merk & Kollegen provides an ideal environment for successful end-to-end customer projects, culminating in material supply for phase I/II clinical studies.

 

The GMP and GLP certified facilities at Labor Dr. Merk & Kollegen are an excellent origin of a successfully developed and manufactured product.

 

Constant innovation in development and process technology is stimulated by close collaboration with academic institutions.